GBT
ABVX

Grove Bank & Trust’s Abivax ABVX Stock Holding History

Grove Bank & Trust’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.86K Sell
74
-2
-3% -$226 ﹤0.01% 646
2026
Q1 		$8.46K Buy
76
+6
+9% +$710 ﹤0.01% 650
2025
Q4 		$9.44K Buy
70
+8
+13% +$873 ﹤0.01% 643
2025
Q3 		$5.26K Buy
+62
New +$3.8K ﹤0.01% 699

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Grove Bank & Trust's ABVX Position: Q2 2026 in Review

Grove Bank & Trust reduced its Abivax (ABVX) stake by 2.6% in Q2 2026, selling an estimated $226 and leaving 74 shares worth $9.86K. The position accounts for ﹤0.01% of the portfolio, ranked #646.

Grove Bank & Trust first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Grove Bank & Trust held 74 shares of Abivax worth $9.86K as of Q2 2026.
  • Grove Bank & Trust sold 2 Abivax shares in Q2 2026, an estimated $226.
  • Abivax made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #646 holding.
  • Grove Bank & Trust first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.